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Norman Bleehen came from an orthodox Jewish background and
was much influenced by the great value both sides of his rabbinical
family placed on academic achievement. He took pride in having
studied and worked in internationally recognised centres of
excellence at the universities of Oxford, London, Cambridge and
Stanford.
Born in Manchester in 1930, he grew up in London. In 1947, he
won a scholarship to Exeter College Oxford to read Medicine,
taking an additional year to do a BA in Physiology and
Biochemistry. A Medical Research Council (MRC) studentship
allowed him to study aspects of the action of insulin in the
Biochemistry Department, for which he was awarded the Gotch
Memorial prize. During his years in Oxford, he was President of
the Oxford University Jewish Society and was influential in the
Interuniversity Jewish Federation.
In 1952, he began his clinical training at the Middlesex Hospital
Medical School, qualifying in 1955. En route, he won prizes for
forensic medicine, orthopaedic surgery, and radiology and radio-
therapy. A house job in the radiotherapy department at the
Middlesex set the direction of Norman’s future career. He much
impressed the then head, Professor (later Sir) Brian Windeyer. In
1957, he gained Membership of the Royal College of Physicians,
before entering the Royal Army Medical Corps for his national
service, initially at the British Military Hospital in Hanover and
then, in 1958, in occupied Berlin. There the allied powers, Britain,
the United States, France and Russia, shared responsibility, on a
rotating monthly basis, for the War Criminals’ gaol at Spandau.
The only inmates were Baldur von Schirach, Albert Speer and,
Hitler’s ex-deputy, Rudolf Hess. When the British were mounting
the guard, it was Norman’s task to examine each inmate weekly,
and to produce a report. As a committed Jew, he was deeply
concerned about taking medical responsibility for these particular
war criminals. Consulting his commanding officer brought the
reminder: ‘This is the army, and that is your job’. But Berlin was
not all duty; Norman was able to enjoy the city, especially the
excellent opera.
On demobilisation in 1959, Norman returned to the Middlesex
Hospital. He was to specialise in radiotherapy and gain a
Fellowship of the Royal College of Radiologists. In 1966, the
MRC awarded him a Lilly travelling fellowship to Stanford
University, where he worked in Professor Henry Kaplan’s
department, much acclaimed for its excellence in relating
laboratory research to treating patients. This appealed to Norman’s
intellect and profoundly influenced his future professional life. He
thoroughly enjoyed Stanford, telling tales of never-to-be-forgotten
fishing trips. Although offered a faculty post there, he chose to
return to the Middlesex, where Sir Brian Windeyer had suggested
that he might ultimately succeed him. Initially, the Duchess of
Bedford Research Fellow, in 1969 he was appointed Professor
of Radiotherapy and head of the Academic Department of
Radiotherapy. He began a laboratory-based research programme
alongside his clinical work and started to build the team he would
subsequently take to Cambridge. That summer he met Tirza Loeb,
an attractive Israeli/Australian PhD student whom he married after
a whirlwind romance. They lived in a beautiful modern house in
Highgate, where walls of glass gave them maximum pleasure from
their garden: a growing enthusiasm. There they extended generous
hospitality and friendship to Norman’s rapidly expanding circle of
colleagues and friends from all over the world.
In 1975, the MRC invited Norman to set up a clinical and
research unit in Cambridge at Addenbrooke’s Hospital. He became
Director of the MRC Clinical Oncology and Radiotherapeutics Unit
(CORU). Cambridge University created a Department of Clinical
Oncology endowed by the Cancer Research Campaign (now
Cancer Research UK), and he was elected its first Professor of
Clinical Oncology and Radiotherapeutics in the same year. Under
his direction, this developed into one of the country’s leading
academic oncology units, both clinically and scientifically.
Clinically, his interests were the treatment of brain tumours,
especially gliomas, and lung cancer, both challenging diseases
where new treatments were needed to improve dismal prognoses.
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current best practise. At this time in the mid-1970s, national
cancer clinical trials supported by the MRC were proliferating
rapidly. The statistical and data management tasks associated with
the good design and successful conduct of clinical trials are
substantial, and as Chairman of the MRC Cancer Therapy
Committee, Norman recognised the need for a dedicated MRC
group to carry out these tasks. He proposed that a Cancer Trials
Office (CTO) be set up within his Cambridge Unit. It was
inaugurated in 1977, taking over responsibility for ongoing trials
as well for as setting up new ones. The CTO was one of his major
achievements; its success led the MRC to create an independent
Cancer Trials Unit.
The team Norman gathered at CORU worked on both
fundamental tumour biology and the development and optimisa-
tion of radiotherapy and chemotherapy. His personal research
interests were in the development and trial of drugs to increase the
efficacy of radiotherapy, and in the use of heat to improve
radiotherapy and chemotherapy. In the course of Phase I trials of
radiosensitisers and chemosensitisers, and many other clinical
studies, he trained a new generation of investigative clinical
oncologists and radiotherapists: now influential consultants and
professors in today’s oncology. The research students and post-
doctoral scientists of CORU, now scattered around the world, are
senior academics or hold powerful positions in the pharmaceutical
industry: a potent legacy of his unit and of his leadership. Norman
displayed an enviable flair for choosing people who would work
together productively in a strong atmosphere of camaraderie. He
was always very supportive of his staff, and invariably delivered on
his promises to them, a rare quality which was much valued.
A substantial body of publications, in excess of 400, bear his
name. Norman also took time to serve on numerous UK boards
and committees, frequently as chairman, as well in range of
international organisations, primarily in Europe. He represented
the UK government in the Europe Against Cancer Programme;
being passionate about smoking prevention campaigns. He served
on the editorial boards of numerous cancer-related journals. He
was nonetheless, a rather modest man, who did not pursue the
limelight, but the worth of his work was recognised and he
received many honours and awards. He was most proud of his
1990 honorary doctorate from the University of Bologna, the oldest
university in the world, and his CBE for services to medicine,
received in 1994, at the height of his career and influence.
Norman and Tirza were very hospitable; family, friends, colleagues
and visitors, many from overseas, enjoyed their lovingly tended
garden and beautiful house in quiet leafy Cambridge. An asparagus
bed, particularly suited to the local soil, was Norman’s special
enthusiasm. Their nephews and niece have had a second home with
them throughout their lives, two are continuing the medical tradition.
Norman retired in 1995, and while he remained a Fellow
of St John’s College and continued to serve on a variety of
committees, he was able to indulge his enthusiasm for opera and
his garden and to travel more extensively with Tirza, especially to
her family in Australia. While there he fell ill with lung cancer, a
cruel fate for a man who had spent so much of his professional
career treating the disease, who had never smoked and had worked
hard to deter people from smoking. Ever an academic clinician,
Norman gained new insights into the disease and was gratified to
find them taken up in clinical trials.
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